Home > Inhibitors & Agonists > Tyrosine Kinase > PDGFR
Cat. No. Product name CAS No.
DC7799 AZD2932 Featured

AZD-2932 is a high affinity inhibitor of VEFGR-2 and PDGFR.

883986-34-3
DC7389 CP-673451

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

343787-29-1
DC5079 Orantinib (TSU-68) Featured

SU6668 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR.

252916-29-3
DC3145 Sunitinib base Featured

Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

557795-19-4
DC7329 Toceranib(SU 11654; PHA 291639) Featured

Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.

356068-94-5
DC8494 Toceranib phosphate(SU 11654) Featured

Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.

874819-74-6
DC28402 Tyrphostin AG1433

Tyrphostin AG1433 (SU1433) is a tyrosine kinases inhibitor. AG1433 is also a selective PDGFRβ and VEGFR-2 (Flk-1/KDR) inhibitor with IC50s of 5.0 μM and 9.3 μM, respectively. Tyrphostin AG1433 prevents blood vessel formation.

168835-90-3
Page 1 / Total 1 FirstPrevNextLastGoto